Navigation Links
Alexza's AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients
Date:9/2/2008

y, Alexza is developing AZ-004 to potentially offer an acute agitation treatment option that provides a fast onset of effect, that is noninvasive and safer to administer than injections, and that allows patients to be active participants in choosing acceptable treatment options.

About AZ-004 (Staccato loxapine)

AZ-004 is the combination of Alexza's proprietary Staccato system with loxapine, a drug belonging to the class of compounds known generally as antipsychotics. The Staccato system is a hand-held, chemically-heated, single dose inhaler designed to generate and deliver excipient-free drug aerosol for deep lung delivery that results in IV-like pharmacokinetics. Alexza has completed four clinical trials with AZ-004 and has announced positive results from all four studies, including a 50 subject Phase 1 study in healthy volunteers, a 129 patient Phase 2 study in agitated schizophrenic patients, a 32 patient multiple-dose tolerability and PK study in non-agitated schizophrenic patients, and a 344 patient Phase 3 study in agitated schizophrenic patients. In July 2008, Alexza initiated a second Phase 3 clinical trial in bipolar disorder patients with acute agitation.

About Symphony Allegro

In December 2006, Alexza entered into a collaboration with Symphony Capital LLC, a biotech-focused private equity firm. Under the terms of the agreement, Alexza and Symphony Capital established Symphony Allegro, Inc., which is providing funding to Alexza to accelerate clinical and other related development activities of Staccato loxapine (AZ-004 and AZ-104) and Staccato alprazolam (AZ-002). Alexza has granted a license to certain intellectual property rights for the selected product candidates. Through a purchase option, Alexza retains the exclusive right, but not the obligation, to acquire 100% of the equity of Symphony Allegro at specified prices during the term of the agreement. If Alexza chooses not to exercise the purchase option, Symphony Allegro re
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
2. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
3. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
4. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
5. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
6. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
7. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
8. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
9. Calabar AB Today Announced New Financing for Continuation of the Phase II Program in Patients With Dry Mouth
10. Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
11. Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... May 27, 2015 Doctors from the ... Children,s National Health System are the first ... treat osteoid osteoma, a benign but painful bone tumor ... an experimental magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) method. ... Niyati Shah , have been treated successfully in ...
(Date:5/27/2015)... May 27, 2015 Water Street ... on the health care industry, announced today that ... one of the world,s leading global health care ... which the firm established in 2013 as a ... investment in developing pharmaceutical products and medical devices. ...
(Date:5/27/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/9ffv95/2015_strategies ... "2015 Strategies in the European Coagulation Testing Market" ... comprehensive five-country report contains 500 pages, 120 tables, ... potential market entrants identify and evaluate business opportunities ... the next five years. The report ...
Breaking Medicine Technology:Children's National first in US to destroy bone tumors with incisionless surgery 2Children's National first in US to destroy bone tumors with incisionless surgery 3Children's National first in US to destroy bone tumors with incisionless surgery 4Water Street Announces Pharmaceutical Development Partnership with Global Health Care Company 2European Coagulation Testing Market Strategies 2015 2
(Date:5/28/2015)... SpendWell Health, an e-commerce marketplace for ... named a “Cool Vendor” by Gartner in the April ... Payers, 2015 by Jeff Cribbs, Constance Sjoquist, Robert ... vendors, products and services in health care technology—which serve ... care payer market. , SpendWell’s solution delivers the ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 The Cancer ... hands-down the most rewarding, researched and heartfelt book the ... thanked Dr. Westman for writing what should be ... Information is power and there is power in action and ... word no one wants to talk about and unfortunately many ...
(Date:5/28/2015)... The 110-mile April 24-26 Face of ... non-profit World T.E.A.M. Sports is featured in a series ... . , Host Bob Calvert and videographers Andy and ... riders, sponsors and staff members. The April 24 Face ... performance by The American Bombshells and a keynote talk ...
(Date:5/27/2015)... Calls Upon Individuals, Organizations and Communities to Serve ... – a “Summer of Service” – seeks the help of ... grow the number of individuals and organizations serving Veterans. ... by inviting the community to visit and explore opportunities to ... 1 – 3:00 p.m. in the auditorium. , “We have ...
(Date:5/27/2015)... a reputable source of 2015 NHL Western Conference Finals tickets ... their series against the Anaheim Ducks with the Ducks currently ahead ... tonight at home, this will tie up the series with game ... in Anaheim. , During the regular season, the Ducks finished ... the Pacific Division by 8 points ahead of the second place ...
Breaking Medicine News(10 mins):Health News:SpendWell Named a “Cool Vendor” by Gartner 2Health News:SpendWell Named a “Cool Vendor” by Gartner 3Health News:SpendWell Named a “Cool Vendor” by Gartner 4Health News:Booksandauthor Cites The Cancer Solution as One of the Most Important Books to Read 2Health News:Videos Document World T.E.A.M. Sports' April 24-26 Face of America Bicycling Ride to Gettysburg 2Health News:Videos Document World T.E.A.M. Sports' April 24-26 Face of America Bicycling Ride to Gettysburg 3Health News:VA Begins “Summer of Service” to Bolster Volunteer Assistance for Veterans 2Health News:VA Begins “Summer of Service” to Bolster Volunteer Assistance for Veterans 3Health News:Blackhawks vs. Ducks NHL Western Conference Finals Tickets: Ticket Down Slashes Ticket Prices on Chicago Blackhawks vs. Anaheim Ducks 2015 NHL Western Conference Finals 2
... latest ... at Vitals, LYNDHURST, N.J., April 7, 2008 Vitals.com, a ... announced that Dr. Robert CJ Krasner has agreed to join,Vitals as ... ways to engage doctor participation on the site and aid,Vitals as ...
... to Support the Solutions for Intelligence Analysis Program, ... 2008 ,Science Applications International Corporation (NYSE: SAI ... in December by the Defense Intelligence,Agency (DIA). This ... Analysis (SIA),program. The maximum dollar value for all ...
... Personal sets interfere with family time, grades and nutrition, study ... your teenager may poignantly plead that he or she is ... bedroom television, health experts recommend that parents stand their ground ... seems to be a good reason for this. The latest ...
... Features Similar to, Market-Leading Systems in an Easy-to-Use, Accessible and Affordable Format ... ... the Accuri Booth at ... 7, 2008 Accuri Cytometers, Inc.,today announced the commercial launch of the Accuri C6 Flow ...
... Adaptis, a leading provider of,Business Process Outsourcing ... has hired Jan Claesson as Senior Vice ... selected for his extensive leadership,background in addition ... growth and,profits through corporate transformations., (Logo: ...
... results when it comes to preventing childhood obesity, according ... Pediatrics. The school-based intervention, which reduced the incidence of ... preventing childhood weight gain and obesity on a large ... of childhood obesity have pushed us to find solutions ...
Cached Medicine News:Health News:Dr. Robert CJ Krasner Appointed to Vitals.com as Independent Advisor 2Health News:SAIC Awarded DIA Intelligence Analysis Contract 2Health News:TV in the Bedroom Is Not a Teen's Best Friend 2Health News:TV in the Bedroom Is Not a Teen's Best Friend 3Health News:Accuri Cytometers Announces Commercial Launch of Revolutionary Accuri C6 Flow Cytometer(TM) System 2Health News:Accuri Cytometers Announces Commercial Launch of Revolutionary Accuri C6 Flow Cytometer(TM) System 3Health News:Accuri Cytometers Announces Commercial Launch of Revolutionary Accuri C6 Flow Cytometer(TM) System 4Health News:Adaptis Names Jan Claesson Senior Vice President and Chief Business Development Officer 2Health News:Changing school environment curbs weight gain in children 2Health News:Changing school environment curbs weight gain in children 3
Portable, easy to align, automatic measurement, automatic fogging. Accurate and dependable readings. Infrared printer communication. Rechargeable battery. Integrates with the TRS-2100 and EPIC-2100 r...
... doubled Nd:YAG laser is mounted on Haag ... selected between 0.2 and 2.0 mJ. The ... and 700 microns. Knobs for laser energy ... on the laser head. The laser system ...
Extremely thin and smooth jaws, jaws open to 5.5 mm, cross action....
Flat handle....
Medicine Products: